Analyst ratings and price targets can significantly influence a stock's performance. In this case, the reiteration of a 'Buy' rating and maintenance of an $18 price target by HC Wainwright & Co. for Rallybio indicates a positive outlook for the stock, which could lead to an increase in its price in the short term.